Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

TIVDAK® Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

or metastatic cervical cancer with disease progression on or after chemotherapy. This FDA action converts the September 2021 accelerated approval of TIVDAK to a full approval. TIVDAK is the first antibody-drug conjugate (ADC) with demonstrated...

Avenacy announces launch of Eptifibatide for Injection in the U.S.

syndrome (ACS) and percutaneous coronary intervention (PCI). Avenacy’s Eptifibatide for Injection is available as a 75 mg/100 mL single-dose vial. In line with Avenacy’s mission to champion patient safety and streamline patient care, Eptifibatide...

Medtronic, Heart-Valve-Surgery.Com launch 'Aortic Stenosis Patient Activation Platform

Cardiology at MetroHealth. Without treatment, up to 50% of patients will die 24 months after the onset of symptoms1. According to Dr. Kendra Grubb, Surgical Director of the Emory Structural Heart & Valve Center, approximately 40%† of patients with...

Onconic Therapeutics gets MFDS nod for JAQBO, a fresh remedy for Gastroesophageal Reflux Disease

Livzon Pharmaceutical Group, the leading seller of PPIs in China for development and commercialization, in a deal value of $127.5 million for Greater China. Onconic Therapeutics is committed to enhancing gastrointestinal treatment and improving...

Nature Publication Highlights the Benefits of Tropis® Intradermal

to improve the performance and outcomes of medicines with its innovative delivery systems, announced the Nature publication1 of Gennova Biopharmaceutical’s Phase 2/3 clinical trial conducted to evaluate the safety and immunogenicity of its novel...

VETIGEL is now available through all major U.S. distributors of veterinary products and services

pre-filled syringe, easy-to-use, and requires no preparation or special storage conditions. Since the product's debut in 2021, veterinary surgeons across North America, Europe, and Asia have increasingly used VETIGEL as the fastest and most...

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy

our results in these and other areas next month at the ASGCT Annual Meeting." About Factor Bioscience Founded in 2011, Factor Bioscience develops technologies for engineering cells to promote health and improve lives. Factor Bioscience is privately...

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Sloan Kettering Cancer Center (MSK), and Syndicate Bio to advance health equity on a global scale. There are roughly 1 million new cancer patients each year in Africa and currently, comprehensive genomic profiling and liquid biopsy testing options...

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

cartilage repair as compared to traditional orthopaedic materials. The ongoing clinical trials (NCT06368700 and NCT06344481) are evaluating the safety and technical performance of the HYALEX Knee Cartilage System in symptomatic patients who require...

ImmunityBio Announces FDA Approval of ANKTIVA®,

a therapeutic cancer vaccine across multiple tumor types, regardless of the site of origin.” ANKTIVA, a first-in-class IL-15 agonist immunotherapy for NMIBC, received Breakthrough Therapy Designation and approval from the FDA based on the safety...

Renibus Therapeutics to Present RBT-1 at European Association for Cardio-Thoracic Surgery

focusing on the prevention and treatment of cardio, renal and metabolic diseases, announced an oral presentation on RBT-1 at the prestigious, RBT-1 (stannic protoporfin / iron sucrose) is a single dose, multi-organ, preconditioning agent that is...

Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies

our Cell Shuttle™ platform. This enables the Cellares IDMO to offer a real end-to-end solution for our customers, providing 10 times higher capacity and up to 50% lower batch price,” said Fabian Gerlinghaus, CEO of Cellares. “Our proprietary...

Moleculin's AML treatment gets EMA's Orphan Drug Designation

shown in Moleculin's European clinical study for the treatment of AML using Annamycin in combination with Cytarabine (MB-106) a preliminary 60% composite complete response (CRc) rate in 2nd line subjects (N=10) and an overall interim CRc of 39% in...

Beckman Coulter's DxI 9000 Immunoassay Analyzer

Coulter's validated HBsAg High Positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO with 96.9% of initially reactive samples being able to be directly reported as positive providing laboratories with...

Scientific article highlights Namodenoson as promising for advanced liver cancer and MASH

efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,600 patients in clinical studies to date. For more information please visit: www.canfite.com.

Study: BRENZAVVY® matches Dapagliflozin in Chinese type 2 diabetes

in adults with type 2 diabetes. BRENZAVVY is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. The randomized, double-blind, active-controlled trial enrolled 406 patients with type 2 diabetes mellitus at...

Algiax Pharmaceuticals expands AP-325 study in chronic neuropathic pain, adds 12 sites in Belgium and France

Algiax Pharmaceuticals, today provided an update on its ongoing Phase 2a study (NCT04429919) with lead candidate AP-325 in patients with chronic neuropathic pain. Based on last year's positive mid-enrollment interim analysis and confirmed...

Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial

Inc. reports early efficacy results showing tumor stabilization in the third patient enrolled in the Company’s Deltacel-01 Phase 1 clinical trial. Deltacel-01 is evaluating Deltacel™ (KB-GDT-01), Kiromic’s allogeneic. off-the-shelf, Gamma Delta...

Pyros Pharma announces VIGPODER™ (vigabatrin)

a nurse educator, reimbursement support, and a clinical pharmacist. For more information, visit PyrosTotalCare.com or call 1-888-760-8330, Monday to Friday, 8 a.m. to 5 p.m. Central Time. About Infantile Spasms: Infantile spasms (IS) is a rare,...

Theralogix Introduces Berberine Enhanced Absorption

by its poor absorption. Berberine Enhanced Absorption solves this problem with berberine phytosome™, which boasts up to 10 times greater bioavailability compared to standard berberine.* Theralogix raises the bar when it comes to premium,...